Notably, Egan et al. [9] reported a high frequency of genetic alterations in the RAS/MAPK pathway across all 21 HS cases analyzed, with mutations observed in NF1, MAP2K1, and PTPN11. The gene discussed is MAP2K1; the disease is histiocytic sarcoma.